Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 16 AL 30

Current view from Alzheimer disease to type 2 diabetes mellitus

Rasool M, Malik A, Qazi AM, Sheikh IA, Manan A, Shaheen S, Qazi MH, Chaudhary AG, Abuzenadah AM, Asif M, Alqahtani MH, Iqbal Z, Shaik MM, Gan SH, Kamal MA.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):533-42. doi: 10.2174/18715273113126660167.

A nanotechnological approach to the management of Alzheimer disease and type 2 diabetes

Alam Q, ZubairAlam M, Karim S, Gan SH, Kamal MA, Jiman-Fatani A, Damanhouri GA, Abuzenadah AM, Chaudhary AG, Haque A.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):478-86. doi: 10.2174/18715273113126660159.

Bacteriophage--a common divergent therapeutic approach for Alzheimer's disease and type II diabetes mellitus

Sohrab SS, Karim S, Kamal MA, Abuzenadah AM, Chaudhary AG, Al-Qahtani MH, Mirza Z.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):491-500. doi: 10.2174/18715273113126660158.

Diabetes of the brain: computational approaches and interventional strategies

Narasimhan K, Govindasamy M, Gauthaman K, Kamal MA, Abuzenadeh AM, Al-Qahtani M, Kanagasabai R.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):408-17. doi: 10.2174/18715273113126660156.

Establishing genomic/transcriptomic links between Alzheimer's disease and type 2 diabetes mellitus by meta-analysis approach

Mirza Z, Kamal MA, Buzenadah AM, Al-Qahtani MH, Karim S.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):501-16. doi: 10.2174/18715273113126660154.

How do periodontal infections affect the onset and progression of Alzheimer's disease?

Shaik MM, Ahmad S, Gan SH, Abuzenadah AM, Ahmad E, Tabrez S, Ahmed F, Kamal MA.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):460-6. doi: 10.2174/18715273113126660152.

Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease

Naseer MI, Bibi F, Alqahtani MH, Chaudhary AG, Azhar EI, Kamal MA, Yasir M.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):305-11. doi: 10.2174/18715273113126660147.

Alzheimer's and type 2 diabetes treatment via common enzyme targeting

Jabir NR, Kamal MA, Abuzenadah AM, Gan SH, Alama MN, Baeesa SS, Tabrez S.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):299-304. doi: 10.2174/18715273113126660145.

The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications

Zemva J, Schubert M.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):322-37. doi: 10.2174/18715273113126660141.

Insulin-degrading enzyme: a link between Alzheimer's and type 2 diabetes mellitus

Haque R, Nazir A.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):259-64. doi: 10.2174/18715273113126660139.

Common cellular and molecular mechanisms underlying Alzheimer's disease and type 2 diabetes: a knowledge-driven approach

Gauthaman K, Pushparaj PN, Rajeshkumar M, Narasimhan K, Al-Qahtani M, Cheung NS, Manikandan J.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):247-58. doi: 10.2174/18715273113126660138.

Molecular linkages between diabetes and Alzheimer's disease: current scenario and future prospects

Dar TA, Sheikh IA, Ganie SA, Ali R, Singh LR, Gan SH, Kamal MA, Zargar MA.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):290-8. doi: 10.2174/18715273113126660135.

Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies

Dai Y, Kamal MA.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):271-82. doi: 10.2174/18715273113126660134.

Editorial: current update on association between Alzheimer's disease and type 2 diabetes: volume I

Kamal MA.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):192-6. doi: 10.2174/1871527313999140307101350.

Sleep in frontotemporal dementia is equally or possibly more disrupted, and at an earlier stage, when compared to sleep in Alzheimer's disease

Bonakis A, Economou NT, Paparrigopoulos T, Bonanni E, Maestri M, Carnicelli L, Di Coscio E, Ktonas P, Vagiakis E, Theodoropoulos P, Papageorgiou SG.

J Alzheimers Dis. 2014;38(1):85-91. doi: 10.3233/JAD-122014.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias